rPhleum

recombinant Phleum pratense allergen · Allergopharma GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for rPhleum, covering 2013-11-08 to 2014-11-13. Get the full timeline:

Most recent: Clinical Trial Update: 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma [Phase 3]